<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04063397</url>
  </required_header>
  <id_info>
    <org_study_id>2018H0312</org_study_id>
    <nct_id>NCT04063397</nct_id>
  </id_info>
  <brief_title>Persistent Postpartum Cardiovascular Dysfunction in Patients With Preeclampsia</brief_title>
  <acronym>ECHO</acronym>
  <official_title>Persistent Postpartum Cardiovascular Dysfunction in Patients With Preeclampsia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Roche Diagnostics</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators plan to enroll women with PE prospectively to evaluate incremental&#xD;
      cardiovascular risk in those who have PE with severe features. This study includes detailed&#xD;
      echocardiographic evaluation at several time points. With the current proposal, the&#xD;
      investigators aim to collect blood to evaluate several biomarkers to determine if there is a&#xD;
      correlation with short and medium-term cardiovascular risk. This opens the door to earlier&#xD;
      detection, treatment and improved cardiovascular outcomes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Preeclampsia (PE) is a multi-system progressive disorder affecting up to 8% of pregnancies.&#xD;
      Epidemiologic studies have shown a significant association between PE and future&#xD;
      cardiovascular disease (CVD) in women. Despite recognition of this relationship, there are no&#xD;
      good markers to help determine which women are at highest risk, in particular as this relates&#xD;
      to long-term cardiovascular risk, the number one cause of mortality in U.S. born women. As&#xD;
      such, the study of PE and cardiovascular outcomes, in particular to identify early markers&#xD;
      for the development of late CVD, provide insight into critical opportunities for early&#xD;
      treatment and modification of disease trajectory in women.&#xD;
&#xD;
      The investigators plan to enroll women with PE prospectively to evaluate incremental&#xD;
      cardiovascular risk in those who have PE with severe features. This study includes detailed&#xD;
      echocardiographic evaluation at several time points. With the current proposal, the&#xD;
      investigators aim to collect blood to evaluate several biomarkers to determine if there is a&#xD;
      correlation with short and medium-term cardiovascular risk. This opens the door to earlier&#xD;
      detection, treatment and improved cardiovascular outcomes.&#xD;
&#xD;
      The investigators hypothesize that preeclampsia with severe features confers a much higher&#xD;
      risk of cardiovascular impairment compared to milder form of preeclampsia and healthy&#xD;
      controls. If the hypothesis proves correct, these findings may change clinical practice by&#xD;
      warranting routine echocardiogram for these patients for early recognition, intervention and&#xD;
      treatment of cardiac dysfunction.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 19, 2019</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 19, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac dysfunction</measure>
    <time_frame>From delivery up to 3-6 months postpartum</time_frame>
    <description>The following parameters will be measured to assess cardiac dysfunction:&#xD;
LV Size/function&#xD;
Biplane Method of Disks LVEF (a4C and 2C views for EDV and ESV)&#xD;
LV Fractional shortening- Septal thickness and PW thickness&#xD;
LV Strain- Basal longitudinal, Mid LV longitudinal, Apical LV longitudinal and Global LV longitudinal strain&#xD;
3D LV EF&#xD;
Tei index&#xD;
Analysis of LV diastolic function- Mitral E wave, Mitral A wave, Mitral e', Mitral E/e', Mitral E/A and Mitral Decel time&#xD;
LA volume&#xD;
RA volume&#xD;
IVC size/compressibility with inspiration&#xD;
RV size/function&#xD;
RV length&#xD;
RV basal width&#xD;
RV FAC %&#xD;
TAPSE&#xD;
S'&#xD;
Tei index&#xD;
TR velocity&#xD;
RVSP&#xD;
TAPSE&#xD;
Longitudinal strain- Basal Longi, Basal longitudinal, Mid LV longitudinal, Apical LV longitudinal and Global LV longitudinal strain&#xD;
Basic valve assessment</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Preeclampsia Severe or Mild</condition>
  <condition>Cardiac Complication</condition>
  <arm_group>
    <arm_group_label>Preeclampsia</arm_group_label>
    <description>40 patients diagnosed with preeclampsia with or without severe features</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>20 Control group of patients without hypertensive disorders of pregnancy</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Echocardiogram</intervention_name>
    <description>Serial echocardiograms will be done on all patients pre-delivery, and at 3-6 months</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Preeclampsia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Blood draw</intervention_name>
    <description>Serial blood draws at same time points as echocardiograms for biomarker levels</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Preeclampsia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        40 patients with preeclampsia with or without severe features 20 control group patients&#xD;
        with no hypertensive disorder of pregnancy&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Females older than 18 years of age&#xD;
&#xD;
          -  Singleton pregnancy&#xD;
&#xD;
          -  The patient is physically and mentally able to understand the informed consent and is&#xD;
             willing to participate in this study&#xD;
&#xD;
          -  Able to speak English&#xD;
&#xD;
          -  Must meet one of the population categories, until each group has reached 20 subjects&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Multiple gestation&#xD;
&#xD;
          -  History of chronic hypertension or cardiac disease including but not limited to&#xD;
             history of heart arrhythmias, congenital heart disease, and use of any cardiac&#xD;
             medication (such as beta blockers, ACE inhibitors, calcium channel blockers) prior to&#xD;
             pregnancy.&#xD;
&#xD;
          -  History of medical problems that may contribute to cardiac dysfunction, including but&#xD;
             not limited to chronic hypertension, poorly controlled hyperthyroidism and diabetes&#xD;
             mellitus.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kara Rood, MD</last_name>
    <phone>614-293-8500</phone>
    <email>kara.rood@osumc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Taryn Summerfield</last_name>
    <phone>614-293-2122</phone>
    <email>summerfield.7@osu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kara Rood, MD</last_name>
      <phone>614-293-8500</phone>
      <email>kara.rood@osumc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 19, 2019</study_first_submitted>
  <study_first_submitted_qc>August 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 21, 2019</study_first_posted>
  <last_update_submitted>August 2, 2021</last_update_submitted>
  <last_update_submitted_qc>August 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Kara M Rood, MD</investigator_full_name>
    <investigator_title>Assistant Professor, Maternal-Fetal Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pre-Eclampsia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

